Access to the information and documents on this portion of the website is restricted for regulatory reasons. You are requested to review the following and confirm where you are currently physically present, and then review the information on the following page. Your confirmation must be true and accurate.
The rights issue and offering of warrants of BBS-Bioactive Bone Substitutes Oyj (the “Offering”) shall be governed by the laws of Finland. No action has been taken, except solely in Finland and Sweden, in order to register the shares, the warrants or the Offering or for the general offering of shares or warrants. This website and the information contained herein are not intended for, and must not be accessed by, or distributed or disseminated to, persons resident or physically present in the United States, Canada, Australia, Hong Kong, South Africa, Singapore, New Zealand or Japan, and this website does not constitute an offer to sell or the solicitation of an offer to buy or acquire, any shares, warrants or other securities of BBS-Bioactive Bone Substitutes Oyj in the United States, Canada, Australia, Hong Kong, South Africa, Singapore, New Zealand or Japan or in any other country where it would be prohibited by local laws or other regulations.
The shares, warrants or other securities of BBS-Bioactive Bone Substitutes Oyj referred to on this website may not be offered or sold in the United States absent registration under the U.S. Securities Act of 1933, as amended, or an applicable exemption from registration thereunder. BBS-Bioactive Bone Substitutes Oyj has not registered and there is no intention to register any portion of the Offering in the United States or to conduct a public offering of securities in the United States. In addition, the shares in BBS-Bioactive Bone Substitutes Oyj have not been and there is no intention to register the shares, warrants or other securities in accordance with the securities laws of Canada, Australia, Hong Kong, South Africa, Singapore, New Zealand or Japan and the shares, warrants or other securities will not be offered or sold in Canada, Australia, Hong Kong, South Africa, Singapore, New Zealand or Japan or to persons who are residents or citizens of these countries or to benefit or in favour of such persons.
Access to the information and documents contained on the following websites may be illegal in certain jurisdictions, and only certain categories of persons may be authorized to access such information and documents. All persons residing outside of the United States, Canada, Australia, Hong Kong, South Africa, Singapore, New Zealand and Japan who wish to have access to the documents contained on this website should first ensure that they are not subject to local laws or regulations that prohibit or restrict their right to access this website, or require registration or approval for any acquisition of securities by them. BBS-Bioactive Bone Substitutes Oyj or its representatives assumes no responsibility if there is a violation of applicable law and regulations by any person.
In order to access the information related to the Offering, you must approve the following:
(i) I have carefully read and understood the instructions and restrictions described above and I approve that they are applicable to me.
(ii) I am not resident of United States, Canada, Australia, Hong Kong, South Africa, Singapore, New Zealand or Japan and I am currently not in these countries.
(iii) If I am resident of any other country than Finland or Sweden if I am currently in any other country than in Finland or Sweden, I have obtained the necessary information about the restrictions applicable to the delivery of this information and my participation in the Offering and I approve that they are applicable to me.
By clicking the link below I confirm that I have read, understood and agree to comply with all restrictions set forth above.
Disclaimer – No access
The information contained in this portion of the website is restricted and is not for release, publication or distribution, directly or indirectly, in whole or in part in, into or from the United States of America, Australia, Canada, Hong Kong, Japan, New Zealand, South Africa, Singapore or any jurisdiction where to do so might constitute a violation of the local securities laws or regulations of such jurisdiction.